OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Plasma for prevention and treatment of glycocalyx degradation in trauma and sepsis
M. S. Kravitz, Nadim Kattouf, Ian J. Stewart, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 12
M. S. Kravitz, Nadim Kattouf, Ian J. Stewart, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 12
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
Eva Stadler, Khai Li Chai, Timothy E. Schlub, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 11, pp. e883-e892
Open Access | Times Cited: 20
Eva Stadler, Khai Li Chai, Timothy E. Schlub, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 11, pp. e883-e892
Open Access | Times Cited: 20
Safety of COVID ‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials
Massimo Franchini, Mario Cruciani, Arturo Casadevall, et al.
Transfusion (2023) Vol. 64, Iss. 2, pp. 388-399
Closed Access | Times Cited: 12
Massimo Franchini, Mario Cruciani, Arturo Casadevall, et al.
Transfusion (2023) Vol. 64, Iss. 2, pp. 388-399
Closed Access | Times Cited: 12
Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients’ variants
Tuba Khawaja, Mikael Kajova, Iris Levonen, et al.
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 423-433
Open Access | Times Cited: 3
Tuba Khawaja, Mikael Kajova, Iris Levonen, et al.
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 423-433
Open Access | Times Cited: 3
Antiplatelet agents for the treatment of adults with COVID-19
Anna-Lena Fischer, Sarah Messer, Rachel Riera, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 9
Anna-Lena Fischer, Sarah Messer, Rachel Riera, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 9
Safety and immunogenicity of homologous prime‐boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study
Yuxiao Wang, Xinquan Lan, Ying Qiao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
Yuxiao Wang, Xinquan Lan, Ying Qiao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2
Angelika Eisele‐Metzger, Judith-Lisa Lieberum, Markus Toews, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Angelika Eisele‐Metzger, Judith-Lisa Lieberum, Markus Toews, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19
Tayler A. Van Denakker, Arwa Z. Al‐Riyami, Rita Feghali, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 7, pp. 501-514
Closed Access | Times Cited: 7
Tayler A. Van Denakker, Arwa Z. Al‐Riyami, Rita Feghali, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 7, pp. 501-514
Closed Access | Times Cited: 7
Spike and nucleocapsid antibody dynamics following SARS ‐CoV ‐2 infection and vaccination: Implications for sourcing COVID ‐19 convalescent plasma from routinely collected blood donations
Clara Di Germanio, Xutao Deng, Brendan G. Balasko, et al.
Transfusion (2024) Vol. 64, Iss. 11, pp. 2063-2074
Open Access | Times Cited: 1
Clara Di Germanio, Xutao Deng, Brendan G. Balasko, et al.
Transfusion (2024) Vol. 64, Iss. 11, pp. 2063-2074
Open Access | Times Cited: 1
Optimizing process and methods for a living systematic review: 30 search updates and three review updates later
Ailsa R. Butler, Jamie Hartmann‐Boyce, Jonathan Livingstone‐Banks, et al.
Journal of Clinical Epidemiology (2023) Vol. 166, pp. 111231-111231
Open Access | Times Cited: 3
Ailsa R. Butler, Jamie Hartmann‐Boyce, Jonathan Livingstone‐Banks, et al.
Journal of Clinical Epidemiology (2023) Vol. 166, pp. 111231-111231
Open Access | Times Cited: 3
Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?
Olivier Garraud, Hervé Watier
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 3, pp. 103726-103726
Open Access | Times Cited: 2
Olivier Garraud, Hervé Watier
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 3, pp. 103726-103726
Open Access | Times Cited: 2
Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise
Edward N. Janoff, Sheldon T. Brown, Ilana Belitskaya‐Lévy, et al.
Contemporary Clinical Trials Communications (2023) Vol. 35, pp. 101190-101190
Open Access | Times Cited: 2
Edward N. Janoff, Sheldon T. Brown, Ilana Belitskaya‐Lévy, et al.
Contemporary Clinical Trials Communications (2023) Vol. 35, pp. 101190-101190
Open Access | Times Cited: 2
Mechanical ventilation core outcome set uptake in Cochrane systematic reviews: A cross‐sectional study
Luis Garegnani, Diego Ivaldi, Mariana Burgos, et al.
Cochrane Evidence Synthesis and Methods (2024) Vol. 2, Iss. 1
Open Access
Luis Garegnani, Diego Ivaldi, Mariana Burgos, et al.
Cochrane Evidence Synthesis and Methods (2024) Vol. 2, Iss. 1
Open Access
Immunoadsorption as a method of antibody donation during the COVID‐19 pandemic
Jannik Rothenburg, Silke Rink‐Baron, Lisa Müller, et al.
Vox Sanguinis (2024) Vol. 119, Iss. 8, pp. 792-800
Open Access
Jannik Rothenburg, Silke Rink‐Baron, Lisa Müller, et al.
Vox Sanguinis (2024) Vol. 119, Iss. 8, pp. 792-800
Open Access
Analysis of risk factors and the effect of specific treatments on the clinical outcome of patients hospitalized for COVID-19 at a university hospital in the Czech Republic
Radana Pařízková, D Astapenko, Martin Balík, et al.
Anesteziologie a intenzivní medicína (2024) Vol. 35, Iss. 3, pp. 142-154
Closed Access
Radana Pařízková, D Astapenko, Martin Balík, et al.
Anesteziologie a intenzivní medicína (2024) Vol. 35, Iss. 3, pp. 142-154
Closed Access
Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma
Caro Verbrugghe, Elise Wouters, Rosalie Devloo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Caro Verbrugghe, Elise Wouters, Rosalie Devloo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial
Benoît Misset, Anh Nguyet Diep, Axelle Bertrand, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access
Benoît Misset, Anh Nguyet Diep, Axelle Bertrand, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access
CONVALESCENT PLASMA THERAPY FOR COVID-19 – DONOR SELECTION STRATEGIES AND ESTABLISHMENT OF A PLASMA BANK
Mikael Kajova, Tamim Khawaja, Iris Levonen, et al.
New Microbes and New Infections (2024) Vol. 62, pp. 101525-101525
Open Access
Mikael Kajova, Tamim Khawaja, Iris Levonen, et al.
New Microbes and New Infections (2024) Vol. 62, pp. 101525-101525
Open Access
O papel do Plasma Convalescente na modulação da resposta inflamatória em pacientes com COVID-19
Mark Aragão dos Santos Silva, Julia Menezes Vignoli, Juliana Silveira Sola, et al.
Research Society and Development (2024) Vol. 13, Iss. 12, pp. e180131247794-e180131247794
Open Access
Mark Aragão dos Santos Silva, Julia Menezes Vignoli, Juliana Silveira Sola, et al.
Research Society and Development (2024) Vol. 13, Iss. 12, pp. e180131247794-e180131247794
Open Access
The Safety Profile of COVID-19 Convalescent Plasma
Michael J. Joyner, Rickey E. Carter, R. Scott Wright, et al.
Current topics in microbiology and immunology (2024)
Closed Access
Michael J. Joyner, Rickey E. Carter, R. Scott Wright, et al.
Current topics in microbiology and immunology (2024)
Closed Access
Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates
Πέτρος Ιωάννου, Athanasios Katsigiannis, Ioanna Papakitsou, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 756-756
Open Access | Times Cited: 1
Πέτρος Ιωάννου, Athanasios Katsigiannis, Ioanna Papakitsou, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 756-756
Open Access | Times Cited: 1
The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review
Massimo Franchini, Daniele Focosi
Life (2023) Vol. 13, Iss. 12, pp. 2322-2322
Open Access | Times Cited: 1
Massimo Franchini, Daniele Focosi
Life (2023) Vol. 13, Iss. 12, pp. 2322-2322
Open Access | Times Cited: 1
For people with mild COVID-19, how does convalescent plasma compare with placebo or with standard plasma?
Sera Tort, Agustín Ciapponi
Cochrane Clinical Answers (2023)
Closed Access
Sera Tort, Agustín Ciapponi
Cochrane Clinical Answers (2023)
Closed Access
